NCT07586124: Pucotenlimab Plus Becotatug Vedotin in Perioperative Treatment of Locally Advanced Resectable Head and Neck Squamous Cell Carcinoma
- State
- Under way
- Phase
- Phase 2
- People
- 80 planned
- Started
- 6 Jul 2026
- Primary completion
- Dec 2027
- Arms
- locally advanced resectable HNSCC Becotatug Vedotin +Pucotenlimab
- Results
- None posted
- 14 May 2026: Trial registered
- 6 Jul 2026: Trial started